Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192.
Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, Streisand J, Powell J, Akesson A, Coppock J, Hoogen Fv, Herrick A, Mayes MD, Veale D, Haas J, Ledbetter S, Korn JH, Black CM, Seibold JR; Cat-192 Study Group; Scleroderma Clinical Trials Consortium.
Denton CP, et al. Among authors: emery p.
Arthritis Rheum. 2007 Jan;56(1):323-33. doi: 10.1002/art.22289.
Arthritis Rheum. 2007.
PMID: 17195236
Free article.
Clinical Trial.